Gene Therapy With Lentivirus Is Acceptable For Clinical Trials, ICH Panel Says
Executive Summary
Lentiviral vectors are acceptable for use in human clinical trials but the safety studies required will depend on the patient population and disease indication under study, an International Conference on Harmonization workgroup said Sept. 9 during a gene therapy workshop in Vienna, Va